Larotrectinib and Boceprevir: Interaction Details

Brand names
Larotrectinib
VitrakviIVitrakvi
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Boceprevir

We don't have a drug information page for Boceprevir yet. Have a question about Boceprevir? Ask a pharmacist, free →

Larotrectinib

Brand names
  • VitrakviI
  • Vitrakvi

What Happens When You Take Larotrectinib With Boceprevir

What can happen when they are taken together (rated Major)

Increased larotrectinib exposure

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Larotrectinib is a , so it should not be used together with a strong CYP3A4 , because the inhibitor may raise larotrectinib exposure and thereby increase the likelihood of adverse reactions. In a study of a single 100 mg larotrectinib dose given with itraconazole, a strong inhibitor, both the (0 to infinity) and the of larotrectinib rose.

When the combination is unavoidable, the larotrectinib dose should be cut by 50%. Once the strong CYP3A4 inhibitor has been stopped for a period of 3 to 5 half-lives, the larotrectinib dose that was used before the inhibitor was started should be resumed.1

The Larotrectinib and Boceprevir Interaction, Explained

Boceprevir can raise the amount of larotrectinib in your body. Boceprevir (a hepatitis C medicine) slows down , a liver enzyme that helps clear larotrectinib (a cancer medicine). When that enzyme is blocked, larotrectinib can build up, which may mean more side effects such as tiredness, dizziness, nausea, or liver changes.

This is based on how the drugs are expected to behave and on a study with a similar enzyme blocker, not on a direct study of these two. Please keep taking both as prescribed and talk with your pharmacist or doctor. Your care team can manage this, for example by adjusting your dose and checking on you more closely.

Mechanism: Boceprevir is a strong . Larotrectinib is a CYP3A4 , so is expected to reduce its and increase exposure (, ), raising the risk of adverse reactions.

  • Evidence: theoretical for this pair. Itraconazole (strong inhibitor) increased larotrectinib AUC(0-inf) and Cmax after a single 100 mg dose.
  • Severity: major. Onset unspecified.
  • Management: avoid when possible. If unavoidable, reduce the larotrectinib dose by 50%. After stopping the inhibitor, wait 3 to 5 half-lives, then resume the prior larotrectinib dose.
  • Monitor for larotrectinib adverse effects during coadministration.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Larotrectinib and Boceprevir Interact

The likely mechanism

of -mediated of larotrectinib

In short: Boceprevir slows CYP3A4, an enzyme that breaks down larotrectinib, so larotrectinib can build up in the body.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When One Drug Raises Another’s Level”, one chapter of our one-minute explainer. See how it works 

How to Manage the Larotrectinib and Boceprevir Interaction

Your care team will usually try to avoid using these two medicines together. If both are needed, the larotrectinib dose is typically reduced by 50%, and your team may monitor you more closely for side effects.

  • Keep taking both medicines exactly as prescribed. Do not change or stop either one on your own.
  • Tell your pharmacist and prescriber about every medicine you take.
  • Report new or worsening side effects promptly.
  • When boceprevir is stopped, your team will decide when to return larotrectinib to your earlier dose (after 3 to 5 half-lives of boceprevir have passed).

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Larotrectinib or Boceprevir need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: VITRAKVI oral capsules, oral solution, larotrectinib oral capsules, oral solution

    When a single 100 mg dose of larotrectinib was given together with itraconazole, a strong , the (0 to infinity) of larotrectinib was 4.3-fold higher and the was 2.8-fold higher than when larotrectinib was given alone.1

Larotrectinib and Boceprevir: Common Questions

How serious is the Larotrectinib and Boceprevir interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Larotrectinib and Boceprevir interaction managed?

Your care team will usually try to avoid using these two medicines together. If both are needed, the larotrectinib dose is typically reduced by 50%, and your team may monitor you more closely for side effects. Keep taking both medicines exactly as prescribed. Do not change or stop either one on your own. Tell your pharmacist and prescriber about every medicine you take. Report new or worsening sid… Management is individual — always follow your own care team's guidance.

Does taking Larotrectinib and Boceprevir at different times of day help?

No. Taking them at different times of day does not prevent this one. Boceprevir slows , an enzyme that breaks down larotrectinib, so larotrectinib can build up in the body. That change lasts while boceprevir is being taken and can continue for a while after the last dose.

Your pharmacist or prescriber can tell you how they will manage it.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Larotrectinib and Boceprevir Interaction

Ask in your own words about taking Larotrectinib and Boceprevir together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: VITRAKVI(R) oral capsules, oral solution, larotrectinib oral capsules, oral solution. Bayer HealthCare Pharmaceuticals Inc (per FDA), Whippany, NJ, 2022. DailyMed
Was this write-up helpful?

Other Serious Interactions of Larotrectinib and Boceprevir

Also serious with Boceprevir

Also serious with Larotrectinib

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Boceprevir

With Larotrectinib

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.